Skip to main content
spacbrain

Comera Life Sciences Holdings

Closed (deSPAC)

Health Care · pre-clinical biologic formulation platform

What it is
A private company in health care preparing to list via a SPAC merger. Full profile in progress.
What it’s doing now
Merging with OTR Acquisition Corp. (OTRA) — closed (despac).
What you should know
Data is still being assembled for this company — what is shown below is everything we have verified so far.
Profile in progress — we only publish what we can verify in filings, and for this company that work isn’t finished. Identity and deal facts above are current; business detail, financials and peers will appear as the filings are parsed.

What the company says about itself

Web research — not audited
What our web check found

[WEB-INTEL 2026-08-26] 5 finding(s) · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "Comera reported revenues of $393 thousand for the three months ended March 31, 2023, compared to $95 thousand for the same period in 2022" [https://www.globenewswire.com/news-release/2023/05/11/2666721/0/en/comera-life-sciences-reports-financial-results-for-first-quarter-2023-and-recent-business-highlights.html] · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "In January 2023, announced the completion of a private placement of 2,406,242 units, at a purchase price of $1.48 per unit, resulting in gross proceeds of approximately $3.6 million and with each unit consisting of one share of the Company’" [https://www.globenewswire.com/news-release/2023/05/11/2666721/0/en/comera-life-sciences-reports-financial-results-for-first-quarter-2023-and-recent-business-highlights.html] · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "Comera had $1.6 million in cash, cash equivalents and restricted cash at March 31, 2023." [https://www.globenewswire.com/news-release/2023/05/11/2666721/0/en/comera-life-sciences-reports-financial-results-for-first-quarter-2023-and-recent-business-highlights.html] · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "On February 21, 2024, the board of directors. Company terminated all of its employees effective as of January 31, 2024" [https://www.publicnow.com/view/6B7FE6144BC796FFE10D1526BE71DFD5A189224C] · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "Squeeze alert: OTRA approves its merger with Comera Life Sciences, albeit with some of highest redemptions we've seen in a while (98.4%)." [https://www.boardroomalpha.com/research/biotech-comera-gets-approval-with-over-98-redemptions]

Source: company web presence · marketing claims are reported as claims, never merged into the filed figures above.

The deal it’s entering

Comera Life Sciences Holdings is merging with OTR Acquisition Corp. (OTRA) currently marked Closed (deSPAC).

Headline equity value—

How to read these numbers: headline vs effective valuation · what a definitive agreement commits

What exactly is being valued, and at what

Common questions

Is Comera Life Sciences Holdings going public?

Comera Life Sciences Holdings has an approved merger with the SPAC OTR Acquisition Corp. (OTRA). Deal status: Closed (deSPAC).

Does Comera Life Sciences Holdings have revenue?

The filings we've parsed don't state a usable revenue figure yet; this profile is updated as new documents land.

Educational content, not investment advice.

Other health care deals